Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm
May 19, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zymeworks Inc. (NASDAQ:...
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
May 19, 2024 20:53 ET
|
Virios Therapeutics
ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
May 19, 2024 20:00 ET
|
Amplexd Therapeutics Inc.
GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
Organic Pigments Market worth $6.0 billion by 2029 Globally, at a CAGR of 6.5% says MarketsandMarkets™
May 19, 2024 19:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 19, 2024 (GLOBE NEWSWIRE) -- The Global Organic Pigments Market is estimated at USD 4.4 billion in 2024 and is projected to reach USD 6.0 billion by 2029, at a CAGR of 6.5% from 2024 to...
Qifu Technology Announces First Quarter 2024 Unaudited Financial Results
May 19, 2024 18:00 ET
|
Qifu Technology, Inc.
SHANGHAI, China, May 19, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its...
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
May 19, 2024 18:00 ET
|
bioLytical Laboratories Inc.
bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)
Music Licensing, Inc. (OTC: SONG) (OTC: SONGD) Announces Implementation of 1-for-500,000 Reverse Stock Split and Reduction of Outstanding Common Shares
May 19, 2024 15:58 ET
|
Music Licensing, Inc.
Naples, FL, May 19, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONGD) today announces a significant milestone in its corporate restructuring, as the company prepares to execute a...
AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
May 19, 2024 15:05 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, May 19, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Akero...
NARI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 19, 2024 14:45 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, May 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of shares of Inari Medical, Inc. (NASDAQ: NARI) common stock between February 24, 2022 and...
Evolv Technologies (EVLV) Slashes 2024 Revenue Expectations, Class Action Pending - Hagens Berman
May 19, 2024 12:32 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) investors who suffered substantial losses to submit your losses now. Class...